Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study

Alexander Kapp; Werner J. Pichler

doi:10.1111/j.1365-4632.2005.02609.x

Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study

International Journal of Dermatology ◽

10.1111/j.1365-4632.2005.02609.x ◽

2006 ◽

Vol 45 (4) ◽

pp. 469-474 ◽

Cited By ~ 37

Author(s):

Alexander Kapp ◽

Werner J. Pichler

Keyword(s):

Effective Treatment ◽

Multicenter Study ◽

Chronic Idiopathic Urticaria ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study

Annals of Oncology ◽

10.1093/annonc/mdl081 ◽

2006 ◽

Vol 17 (7) ◽

pp. 1096-1102 ◽

Cited By ~ 52

Author(s):

D.A. Richards ◽

K.A. Boehm ◽

D.M. Waterhouse ◽

D.J. Wagener ◽

S.S. Krishnamurthi ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Multicenter Study ◽

Advanced Pancreatic Cancer ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Ganciclovir Treatment of Cytomegalovirus Colitis in AIDS: A Randomized, Double-Blind, Placebo-Controlled Multicenter Study

The Journal of Infectious Diseases ◽

10.1093/infdis/167.2.278 ◽

1993 ◽

Vol 167 (2) ◽

pp. 278-282 ◽

Cited By ~ 98

Author(s):

Douglas T. Dieterich ◽

Donald P. Kotler ◽

David F. Busch ◽

Clyde Crumpacker ◽

Charles Du Mond ◽

...

Keyword(s):

Multicenter Study ◽

Double Blind ◽

Double Blind Placebo ◽

Cytomegalovirus Colitis ◽

Ganciclovir Treatment

Download Full-text

BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]

Breast Cancer Targets and Therapy ◽

10.2147/bctt.s84920 ◽

2015 ◽

pp. 163

Author(s):

Steen Lindkær-Jensen ◽

Stig Larsen ◽

Kritiya Butthongkomvong ◽

Alexey Manikas ◽

Ekaterina Trishkina ◽

...

Keyword(s):

Breast Cancer ◽

Multicenter Study ◽

Stage Iv ◽

Treatment Phase ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Stage Iv Breast Cancer

Download Full-text

P.1.030 Double-blind, placebo-controlled,multicenter study evaluating nemifitide, a new pentapeptide antidepressant, when given daily or every other day for three weeks in the treatment of major depressive disorder

European Neuropsychopharmacology ◽

10.1016/s0924-977x(05)80258-5 ◽

2005 ◽

Vol 15 ◽

pp. S119

Author(s):

J.P. Feighner ◽

L. Sverdlov ◽

J. Hlavka ◽

G. Nicolau ◽

G. Tonelli ◽

...

Keyword(s):

Major Depressive Disorder ◽

Depressive Disorder ◽

Multicenter Study ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The Effect of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients With Superficial Bladder Cancer: Results of a Randomized, Prospective, Double-Blind, Placebo Controlled, Multicenter Study

The Journal of Urology ◽

10.1016/j.juro.2006.04.104 ◽

2006 ◽

Vol 176 (3) ◽

pp. 935-939 ◽

Cited By ~ 108

Author(s):

Marc Colombel ◽

Fabien Saint ◽

Dominique Chopin ◽

Bernard Malavaud ◽

Ludovic Nicolas ◽

...

Keyword(s):

Bladder Cancer ◽

Multicenter Study ◽

Superficial Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Antenatal allopurinol for reduction of birth asphyxia induced brain damage (ALLO-Trial); a randomized double blind placebo controlled multicenter study

BMC Pregnancy and Childbirth ◽

10.1186/1471-2393-10-8 ◽

2010 ◽

Vol 10 (1) ◽

Cited By ~ 48

Author(s):

Joepe J Kaandorp ◽

Manon JNL Benders ◽

Carin MA Rademaker ◽

Helen L Torrance ◽

Martijn A Oudijk ◽

...

Keyword(s):

Brain Damage ◽

Multicenter Study ◽

Birth Asphyxia ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

T1148 Safety and Tolerability of Twice-Daily Balsalazide Tablets: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

Gastroenterology ◽

10.1016/s0016-5085(08)62307-0 ◽

2008 ◽

Vol 134 (4) ◽

pp. A-494 ◽

Cited By ~ 1

Author(s):

Ronald E. Pruitt ◽

Alan A. Rosen ◽

Lawrence Wruble ◽

Shahriar Sedghi ◽

Roland D. Shepard ◽

...

Keyword(s):

Multicenter Study ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study

Movement Disorders ◽

10.1002/mds.26235 ◽

2015 ◽

Vol 30 (7) ◽

pp. 1009-1009

Author(s):

Hasmet A. Hanagasi

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Cognitive Deficits ◽

Multicenter Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with symptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study

JAMA ◽

10.1001/jama.265.12.1538 ◽

1991 ◽

Vol 265 (12) ◽

pp. 1538-1544 ◽

Cited By ~ 9

Author(s):

E. M. Hersh

Keyword(s):

Hiv Infection ◽

Multicenter Study ◽

Sodium Diethyldithiocarbamate ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The effect of ofloxacin on bacillus calmette-guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2007.03.004 ◽

2007 ◽

Vol 25 (3) ◽

pp. 272

Author(s):

H. Barton Grossman

Keyword(s):

Bladder Cancer ◽

Multicenter Study ◽

Superficial Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Double Blind ◽

Double Blind Placebo

Download Full-text